Fund HoldingsvenBio Partners LLC

Total Portfolio Value
$519.38M
Total Bought
$212.28M
Total Sold
$6.91M
Net Transaction
+$205.37M
Filing Period:
Securities
SharesValue ($K)
Q1 2026
Q2 2026
Change
Q1 2026
Q2 2026
Weight (%)
Change
PARABILIS MEDICINES INC05,266,697+5,266,6970144,14927.75%+144,149
ACHIEVE LIFE SCIENCE INC05,914,720+5,914,720038,6237.44%+38,623
PHARVARIS N V
COM
4,639,3044,643,430+4,126131,060160,57030.92%+29,509
ALUMIS INC4,528,4084,528,408099,761127,42924.53%+27,669
HARMONY BIOSCIENCES HLDGS IN(HRMY)489,194472,194-17,00013,70217,1933.31%+3,490
ALX ONCOLOGY HLDGS INC(ALXO)12,884,63812,884,638025,83426,6715.14%+838
LYELL IMMUNOPHARMA INC(LYEL)337,697337,69706,7744,7450.91%-2,030
ARTIVA BIOTHERAPEUTICS INC(ARTV)531,3370-531,3373,4220-3,422
Page 1 of 1
venBio Partners LLC — 13F Holdings — Q2 2026 | TickerTrail